0

Vasculitides Collection
 1-20 of 170 Articles
Original Research |  5 November 2013
The Association Between Dietary Patterns at Midlife and Health in Aging: An Observational Study
Cécilia Samieri, PhD; Qi Sun, MD, ScD; Mary K. Townsend, ScD; et al.
Ann Intern Med. 2013;159(9):584-591. doi:10.7326/0003-4819-159-9-201311050-00004
Original Research |  4 October 2011
Pentraxin-3 as a Marker of Disease Activity in Takayasu Arteritis
Lorenzo Dagna, MD; Fulvio Salvo, MD; Mirta Tiraboschi, MD; et al.
Ann Intern Med. 2011;155(7):425-433. doi:10.7326/0003-4819-155-7-201110040-00005
Articles |  19 May 2009
Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis: A Randomized Trial
Kirsten de Groot, MD; Lorraine Harper, MD, PhD; David R.W. Jayne, MD, PhD; et al.
Ann Intern Med. 2009;150(10):670-680. doi:10.7326/0003-4819-150-10-200905190-00004
Articles |  6 November 2007
Antiproteinase 3 Antineutrophil Cytoplasmic Antibodies and Disease Activity in Wegener Granulomatosis
Javier D. Finkielman, MD; Peter A. Merkel, MD, MPH; Darrell Schroeder, MS; et al.
Ann Intern Med. 2007;147(9):611-619. doi:10.7326/0003-4819-147-9-200711060-00005
Articles |  1 May 2007
Infliximab for Maintenance of Glucocorticosteroid-Induced Remission of Giant Cell Arteritis: A Randomized Trial
Gary S. Hoffman, MD; Maria C. Cid, MD; Karen E. Rendt-Zagar, MD; et al.
Ann Intern Med. 2007;146(9):621-630. doi:10.7326/0003-4819-146-9-200705010-00004
Articles |  1 November 2005
Predictors of Relapse and Treatment Resistance in Antineutrophil Cytoplasmic Antibody–Associated Small-Vessel Vasculitis
Susan L. Hogan, PhD, MPH; Ronald J. Falk, MD; Hyunsook Chin, MPH; et al.
Ann Intern Med. 2005;143(9):621-631. doi:10.7326/0003-4819-143-9-200511010-00005
Articles |  1 November 2005
Antineutrophil Cytoplasmic Antibodies and the Churg–Strauss Syndrome
Régis Sablé-Fourtassou, MD; Pascal Cohen, MD; Alfred Mahr, MD; et al.
Ann Intern Med. 2005;143(9):632-638. doi:10.7326/0003-4819-143-9-200511010-00006
Editorials |  1 November 2005
Are There Different Forms of Life in the Antineutrophil Cytoplasmic Antibody Universe?
Gary S. Hoffman, MD, MS; Carol A. Langford, MD, MHS
Ann Intern Med. 2005;143(9):683-685. doi:10.7326/0003-4819-143-9-200511010-00012
Articles |  19 April 2005
Brief Communication: High Incidence of Venous Thrombotic Events among Patients with Wegener Granulomatosis: The Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study
Peter A. Merkel, MD, MPH; Grace H. Lo, MD; Janet T. Holbrook, PhD, MPH; et al.
Ann Intern Med. 2005;142(8):620-626. doi:10.7326/0003-4819-142-8-200505030-00011
Reviews |  1 March 2005
Meta-Analysis: Test Performance of Ultrasonography for Giant-Cell Arteritis
Fotini B. Karassa, MD; Miltiadis I. Matsagas, MD; Wolfgang A. Schmidt, MD; et al.
Ann Intern Med. 2005;142(5):359-369. doi:10.7326/0003-4819-142-5-200503010-00011
Reviews |  16 September 2003
Giant-Cell Arteritis and Polymyalgia Rheumatica
Cornelia M. Weyand, MD; Jörg J. Goronzy, MD
Ann Intern Med. 2003;139(6):505-515. doi:10.7326/0003-4819-139-6-200309160-00015
Articles |  20 August 2002
Is Duplex Ultrasonography Useful for the Diagnosis of Giant-Cell Arteritis?
Carlo Salvarani, MD; Mauro Silingardi, MD; Angelo Ghirarduzzi, MD; et al.
Ann Intern Med. 2002;137(4):232-238. doi:10.7326/0003-4819-137-4-200208200-00006
Articles |  16 January 2001
Combined Treatment of Giant-Cell Arteritis with Methotrexate and Prednisone: A Randomized, Double-Blind, Placebo-Controlled Trial
Juan A. Jover, MD, PhD; César Hernández-García, MD, PhD; Inmaculada C. Morado, MD; et al.
Ann Intern Med. 2001;134(2):106-114. doi:10.7326/0003-4819-134-2-200101160-00010
Brief Communications |  2 March 1999
Mycophenolate Mofetil for the Treatment of Takayasu Arteritis: Report of Three Cases
Erica Daina, MD; Arrigo Schieppati, MD; Giuseppe Remuzzi, MD
Ann Intern Med. 1999;130(5):422-426. doi:10.7326/0003-4819-130-5-199903020-00013
Articles |  1 September 1998
Limitations of the 1990 American College of Rheumatology Classification Criteria in the Diagnosis of Vasculitis
Jaya K. Rao, MD, MHS; Nancy B. Allen, MD; Theodore Pincus, MD
Ann Intern Med. 1998;129(5):345-352. doi:10.7326/0003-4819-129-5-199809010-00001
Brief Communications |  1 September 1998
Interferon-α Treatment of Four Patients with the Churg-Strauss Syndrome
Efstratios Tatsis, MD; Armin Schnabel, MD; Wolfgang L. Gross, MD
Ann Intern Med. 1998;129(5):370-374. doi:10.7326/0003-4819-129-5-199809010-00004
Reviews |  15 July 1998
Relapsing Polychondritis
David E. Trentham, MD; Christine H. Le, MBBS, FRACP
Ann Intern Med. 1998;129(2):114-122. doi:10.7326/0003-4819-129-2-199807150-00011
Articles |  15 March 1998
Thalidomide in the Treatment of the Mucocutaneous Lesions of the Behcet Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
Vedat Hamuryudan, MD; Cem Mat, MD; Sebahattin Saip, MD; et al.
Ann Intern Med. 1998;128(6):443-450. doi:10.7326/0003-4819-128-6-199803150-00004
Editorials |  15 March 1998
Behcet Disease and the Emergence of Thalidomide
George E. Ehrlich, MD
Ann Intern Med. 1998;128(6):494-495. doi:10.7326/0003-4819-128-6-199803150-00011
Brief Reports |  15 May 1996
Successful Treatment of Behcet Disease with Pentoxifylline
Kozo Yasui, MD; Kouichi Ohta, MD; Masakazu Kobayashi, MD; et al.
Ann Intern Med. 1996;124(10):891-893. doi:10.7326/0003-4819-124-10-199605150-00005
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)